Late rebound of dabigatran levels after idarucizumab reversal in two patients with severe renal failure

Eur J Anaesthesiol. 2017 Jun;34(6):400-402. doi: 10.1097/EJA.0000000000000617.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antibodies, Monoclonal, Humanized / blood*
  • Antithrombins / adverse effects
  • Antithrombins / blood*
  • Dabigatran / adverse effects
  • Dabigatran / blood*
  • Female
  • Hemorrhage / blood
  • Hemorrhage / chemically induced
  • Hemorrhage / diagnosis
  • Humans
  • Renal Insufficiency / blood*
  • Renal Insufficiency / diagnosis
  • Renal Insufficiency / therapy
  • Severity of Illness Index*
  • Time Factors

Substances

  • Antibodies, Monoclonal, Humanized
  • Antithrombins
  • idarucizumab
  • Dabigatran